Related references
Note: Only part of the references are listed.Chronic Lung Disease in the Preterm Infant Lessons Learned from Animal Models
Anne Hilgendorff et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Bronchopulmonary dysplasia: The earliest and perhaps the longest lasting obstructive lung disease in humans
Silvia Carraro et al.
EARLY HUMAN DEVELOPMENT (2013)
Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury
O. Eickmeier et al.
MUCOSAL IMMUNOLOGY (2013)
DHA supplementation: Current implications in pregnancy and childhood
Lynette K. Rogers et al.
PHARMACOLOGICAL RESEARCH (2013)
MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia
Jie Dong et al.
BMC GENOMICS (2012)
Health care utilization by preterm infants with respiratory complications in Quebec
Jennifer S. Landry et al.
CANADIAN RESPIRATORY JOURNAL (2012)
Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: Impact of the physiologic definition
Girija Natarajan et al.
EARLY HUMAN DEVELOPMENT (2012)
Arginyl-glutamine dipeptide or docosahexaenoic acid attenuate hyperoxia-induced lung injury in neonatal mice
Liya Ma et al.
NUTRITION (2012)
Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation
Antonio Recchiuti et al.
FRONTIERS IN IMMUNOLOGY (2012)
Inflammation and lung maturation from stretch injury in preterm fetal sheep
Noah H. Hillman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Maternal Docosahexaenoic Acid Supplementation Decreases Lung Inflammation in Hyperoxia-Exposed Newborn Mice
Lynette K. Rogers et al.
JOURNAL OF NUTRITION (2011)
Decreased Postnatal Docosahexaenoic and Arachidonic Acid Blood Levels in Premature Infants are Associated with Neonatal Morbidities
Camilia R. Martin et al.
JOURNAL OF PEDIATRICS (2011)
Resolvin D1 protects mice from LPS-induced acute lung injury
Bin Wang et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
Specialized pro-resolving lipid mediators in the inflammatory response: An update
Gerard Bannenberg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Postnatal Docosahexaenoic Acid Deficiency Is an Inevitable Consequence of Current Recommendations and Practice in Preterm Infants
Alexandre Lapillonne et al.
NEONATOLOGY (2010)
Hyperoxia-derived lung damage in preterm infants
Vineet Bhandari
SEMINARS IN FETAL & NEONATAL MEDICINE (2010)
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-β and Wnt signaling and is protected by rosiglitazone
Chiranjib Dasgupta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Lysyl Oxidase Activity Is Dysregulated during Impaired Alveolarization of Mouse and Human Lungs
Arun Kumarasamy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The 'new' bronchopulmonary dysplasia: challenges and commentary
T. Allen Merritt et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2009)
Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants
Suh-Fang Jeng et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TGF-β-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung
Hidehiko Nakanishi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice:: The role of heme oxygenase-1
Sheng-Wei Jin et al.
ANESTHESIA AND ANALGESIA (2007)
Hyperoxia modulates TGF-β/BMP signaling in a mouse model of bronchopulmonary dysplasia
Miguel A. Alejandre-Alcazar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Angiogenesis in lung development, injury and repair: Implications for chronic lung disease of prematurity
Bernard Thebaud
NEONATOLOGY (2007)
Statistical analysis of real-time PCR data
JS Yuan et al.
BMC BIOINFORMATICS (2006)
Vascular endothelial growth factor in the lung
NF Voelkel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury -: Evidence that angiogenesis participates in alveolarization
B Thébaud et al.
CIRCULATION (2005)
Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia
J Bourbon et al.
PEDIATRIC RESEARCH (2005)
Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema
H Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress
GTA Wagenaar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Conditional overexpression of bioactive transforming growth factor-β1 in neonatal mouse lung -: A new model for bronchopulmonary dysplasia?
AG Vicencio et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Regulation of TGF-β ligand and receptor expression in neonatal rat lungs exposed to chronic hypoxia
AG Vicencio et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Impaired distal airway development in mice lacking elastin
DP Wendel et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Share Paper
